obesity drug news today glp-1 2025 Alarming rise in weight loss overdoses GLP-1 Pipeline Update: August 2025
Description
The influence of preceding treatment was assessed using propensity score-based inverse probability weighting (PS-IPW)

Important limitations include: Most evidence derives from preclinical or observational studies No randomized controlled trials specifically evaluate tirzepatide for autoimmune disease Mechanisms remain incompletely understood Clinical translation of anti-inflammatory effects is uncertain There is currently no established clinical evidence that tirzepatide effectively treats autoimmune diseases

Front Immunol 7:154 Zietek T, Waldschmitt N, Rath E (2017) Role of incretin hormones in bowel diseases

We are already seeing consistent drops in snack purchases across the US and UK, yet, a policy shift in either country could change everything
Slow titration does not just improve comfort

Not for Medical or Rapid Weight-Loss Use Patchie's ingredients are supportive, not therapeutic